Company Overview of Garnet Biotherapeutics, Inc.
Garnet Biotherapeutics, Inc. operates as a cell therapy company that focuses on dermal-based regenerative therapies. The company offers cell-product GBT 009 that releases anti-inflammatory and pro-healing factors to accelerate healing and reduce scarring, as well as reduces inflammation and suppresses the autoimmune response. Its products are used in post-surgical wound repair, scar revision, burns, and various dermatologic indications. Garnet Biotherapeutics, Inc. was formerly known as Neuronyx, Inc. The company was founded in 2000 and is based in Malvern, Pennsylvania.
490 Lapp Road
Malvern, PA 19355
Founded in 2000
Key Executives for Garnet Biotherapeutics, Inc.
Garnet Biotherapeutics, Inc. Key Developments
Similar Private Companies By Industry
|Endacea, Inc.||United States|
|Applied StemCell, Inc.||United States|
|Kenna Technologies, Inc.||United States|
|PrimeGen Biotech LLC||United States|
|fqubed, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Garnet Biotherapeutics, Inc., please visit www.garnetbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.